<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37091856</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Subacute thyroiditis following COVID-19: A systematic review.</ArticleTitle><Pagination><StartPage>1126637</StartPage><MedlinePgn>1126637</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1126637</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2023.1126637</ELocationID><Abstract><AbstractText Label="BACKGROUND">Subacute thyroiditis (SAT) is a self-limiting thyroid inflammatory disease occurring specifically after upper respiratory tract infections. Since COVID-19 is a respiratory disease leading to multi-organ involvements, we aimed to systematically review the literature regarding SAT secondary to COVID-19.</AbstractText><AbstractText Label="METHODS">We searched Scopus, PubMed/MEDLINE, Cochrane, Web of Science, ProQuest, and LitCovid databases using the terms "subacute thyroiditis" and "COVID-19" and their synonyms from inception to November 3, 2022. We included the original articles of the patients with SAT secondary to COVID-19. Studies reporting SAT secondary to COVID-19 vaccination or SAT symptoms' manifestation before the COVID-19 infection were not included.</AbstractText><AbstractText Label="RESULTS">Totally, 820 articles were retained. Having removed the duplicates, 250 articles remained, out of which 43 articles (40 case reports and three case series) with a total of 100 patients, were eventually selected. The patients aged 18-85 years (Mean: 42.70, SD: 11.85) and 68 (68%) were women. The time from the onset of COVID-19 to the onset of SAT symptoms varied from zero to 168 days (Mean: 28.31, SD: 36.92). The most common symptoms of SAT were neck pain in 69 patients (69%), fever in 54 (54%), fatigue and weakness in 34 (34%), and persistent palpitations in 31 (31%). The most common ultrasonographic findings were hypoechoic regions in 73 (79%), enlarged thyroid in 46 (50%), and changes in thyroid vascularity in 14 (15%). Thirty-one patients (31%) were hospitalized, and 68 (68%) were treated as outpatients. Corticosteroids were the preferred treatment in both the inpatient and outpatient settings (25 inpatients (81%) and 44 outpatients (65%)). Other preferred treatments were nonsteroidal anti-inflammatory drugs (nine inpatients (29%) and 17 outpatients (25%)) and beta-blockers (four inpatients (13%) and seven outpatients (10%)). After a mean duration of 61.59 days (SD: 67.07), 21 patients (23%) developed hypothyroidism and thus, levothyroxine-based treatment was used in six of these patients and the rest of these patients did not receive levothyroxine.</AbstractText><AbstractText Label="CONCLUSION">SAT secondary to COVID-19 seems to manifest almost similarly to the conventional SAT. However, except for the case reports and case series, lack of studies has limited the quality of the data at hand.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Meftah, Rahmati, Zari Meidani, Khodadadi, Chitzan-Zadeh, Esfahanian and Afshar.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meftah</LastName><ForeName>Elahe</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahmati</LastName><ForeName>Rahem</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Students Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zari Meidani</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Students Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khodadadi</LastName><ForeName>Sanaz</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Students Research Committee, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chitzan-Zadeh</LastName><ForeName>Kosar</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Students Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esfahanian</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Vali-Asr Hospital, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afshar</LastName><ForeName>Shiva</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>Q51BO43MG4</RegistryNumber><NameOfSubstance UI="D013974">Thyroxine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013974" MajorTopicYN="N">Thyroxine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013968" MajorTopicYN="Y">Thyroiditis, Subacute</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">De Quervain thyroiditis</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">long-term COVID-19 symptoms</Keyword><Keyword MajorTopicYN="N">subacute thyroiditis (SAT)</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">thyroid</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>4</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37091856</ArticleId><ArticleId IdType="pmc">PMC10115182</ArticleId><ArticleId IdType="doi">10.3389/fendo.2023.1126637</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Temgoua MN, Endomba FT, Nkeck JR, Kenfack GU, Tochie JN, Essouma M. Coronavirus disease 2019 (COVID-19) as a multi-systemic disease and its impact in low- and middle-income countries (LMICs). SN Compr Clin Med (2020) 2(9):1377&#x2013;87. doi: 10.1007/s42399-020-00417-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00417-7</ArticleId><ArticleId IdType="pmc">PMC7371790</ArticleId><ArticleId IdType="pubmed">32838173</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 syndrome: The persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med (Lausanne) (2021) 8:653516. doi: 10.3389/fmed.2021.653516</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.653516</ArticleId><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty T, Jamal RF, Battineni G, Teja KV, Marto CM, Spagnuolo G. A review of prolonged post-COVID-19 symptoms and their implications on dental management. Int J Environ Res Public Health (2021) 18(10). doi: 10.3390/ijerph18105131</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18105131</ArticleId><ArticleId IdType="pmc">PMC8151698</ArticleId><ArticleId IdType="pubmed">34066174</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimboli P, Cappelli C, Croce L, Scappaticcio L, Chiovato L, Rotondi M. COVID-19-Associated subacute thyroiditis: Evidence-based data from a systematic review. Front Endocrinol (Lausanne) (2021) 12:707726. doi: 10.3389/fendo.2021.707726</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.707726</ArticleId><ArticleId IdType="pmc">PMC8511511</ArticleId><ArticleId IdType="pubmed">34659109</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfadda AA, Sallam RM, Elawad GE, Aldhukair H, Alyahya MM. Subacute thyroiditis: Clinical presentation and long term outcome. Int J Endocrinol (2014) 2014:794943. doi: 10.1155/2014/794943</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/794943</ArticleId><ArticleId IdType="pmc">PMC3996955</ArticleId><ArticleId IdType="pubmed">24803929</ArticleId></ArticleIdList></Reference><Reference><Citation>Stasiak M, Lewi&#x144;ski A. New aspects in the pathogenesis and management of subacute thyroiditis. Rev Endocr Metab Disord (2021) 22(4):1027&#x2013;39. doi: 10.1007/s11154-021-09648-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09648-y</ArticleId><ArticleId IdType="pmc">PMC8096888</ArticleId><ArticleId IdType="pubmed">33950404</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihara E, Ohye H, Amino N, Takata K, Arishima T, Kudo T, et al. . Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med (2008) 47(8):725&#x2013;9. doi: 10.2169/internalmedicine.47.0740</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.47.0740</ArticleId><ArticleId IdType="pubmed">18421188</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T, Kakimoto H, Morita S, Mizota M, Iwamoto J. Subacute thyroiditis presenting with creeping in a 6-year-old boy. Clin Pediatr Endocrinol (2021) 30(1):75&#x2013;8. doi: 10.1297/cpe.30.75</Citation><ArticleIdList><ArticleId IdType="doi">10.1297/cpe.30.75</ArticleId><ArticleId IdType="pmc">PMC7783128</ArticleId><ArticleId IdType="pubmed">33446958</ArticleId></ArticleIdList></Reference><Reference><Citation>Volp&#xe9; R, Row VV, Ezrin C. Circulating viral and thyroid antibodies in subacute thyroiditis. J Clin Endocrinol Metab (1967) 27(9):1275&#x2013;84. doi: 10.1210/jcem-27-9-1275</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem-27-9-1275</ArticleId><ArticleId IdType="pubmed">4292248</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimos G, Pappas G, Akritidis N. Subacute thyroiditis in the course of novel H1N1 influenza infection. Endocrine (2010) 37(3):440&#x2013;1. doi: 10.1007/s12020-010-9327-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-010-9327-3</ArticleId><ArticleId IdType="pubmed">20960165</ArticleId></ArticleIdList></Reference><Reference><Citation>Aemaz Ur Rehman M, Farooq H, Ali MM, Ebaad Ur Rehman M, Dar QA, Hussain A. The association of subacute thyroiditis with COVID-19: A systematic review. SN Compr Clin Med (2021) 3(7):1515&#x2013;27. doi: 10.1007/s42399-021-00912-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-021-00912-5</ArticleId><ArticleId IdType="pmc">PMC8082479</ArticleId><ArticleId IdType="pubmed">33942028</ArticleId></ArticleIdList></Reference><Reference><Citation>Popescu M, Ghemigian A, Vasile CM, Costache A, Carsote M, Ghenea AE. The new entity of subacute thyroiditis amid the COVID-19 pandemic: From infection to vaccine. Diagnostics (2022) 12(4):960&#x2013;. doi: 10.3390/diagnostics12040960</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12040960</ArticleId><ArticleId IdType="pmc">PMC9030970</ArticleId><ArticleId IdType="pubmed">35454008</ArticleId></ArticleIdList></Reference><Reference><Citation>Sariyildiz GT, &#xc7;&#x130;&#xc7;Ek C, Arslan A&#x130;, Dem&#x130;R ME. COVID-19 and COVID-19 vaccines-related subacute thyroiditis: analysis of a case series. Anatolian Curr Med J (2022) 4(2):138&#x2013;45. doi: 10.38053/acmj.1061185</Citation><ArticleIdList><ArticleId IdType="doi">10.38053/acmj.1061185</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. . The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. System Rev (2021) 10(1):89. doi:&#xa0;10.1186/s13643-021-01626-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-021-01626-4</ArticleId><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>
Who . Coronavirus disease (COVID-19) [Internet]. (2022) [cited 2022 Sep 20]. Available from: https://www.who.int/health-topics/coronavirus#tab=tab_3.</Citation></Reference><Reference><Citation>
Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. . Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z (Editors). Joanna Briggs Institute Reviewer's Manual. The Joanna Briggs Institute. (2017). Available from https://reviewersmanual.joannabriggs.org/.</Citation></Reference><Reference><Citation>Abreu R, Miguel R, Saieg M. Subacute (De quervain) thyroiditis during the COVID-19 pandemic. Cancer Cytopathol (2021) 129(11):844&#x2013;6. doi: 10.1002/cncy.22449</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncy.22449</ArticleId><ArticleId IdType="pmc">PMC8239629</ArticleId><ArticleId IdType="pubmed">33970557</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Shammaa MS, Abdlkadir AS. A case of post COVID-19 subacute thyroiditis. Clin Case Rep (2022) 10(7):e6092. doi: 10.1002/ccr3.6092</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.6092</ArticleId><ArticleId IdType="pmc">PMC9295679</ArticleId><ArticleId IdType="pubmed">35865769</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;lvarez Mart&#xed;n MC, Del Peso Gilsanz C, Hern&#xe1;ndez L&#xf3;pez A. Subacute de quervain thyroiditis after SARS-CoV-2 infection. Endocrinol Diabetes Nutr (Engl Ed) (2021) 68(10):754&#x2013;755. doi:&#xa0;10.1016/j.endien.2020.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.endien.2020.10.010</ArticleId><ArticleId IdType="pmc">PMC8651488</ArticleId><ArticleId IdType="pubmed">34924165</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf S, Imran MA, Ashraf S, Hafsa H-T, Khalid S, Akram MK, et al. . COVID-19: A potential trigger for thyroid dysfunction. Am J Med Sci (2021) 362(3):303&#x2013;7. doi: 10.1016/j.amjms.2021.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2021.05.013</ArticleId><ArticleId IdType="pmc">PMC8137358</ArticleId><ArticleId IdType="pubmed">34023311</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayhan M, Guner R. A subacute thyroiditis case after SARS-CoV-2 infection: A case report and current literature review. Haseki Tip Bulteni (2021) 59:54&#x2013;6. doi: 10.4274/haseki.galenos.2021.7126</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/haseki.galenos.2021.7126</ArticleId></ArticleIdList></Reference><Reference><Citation>Baykan EK, Carlioglu A. Subacute thyroiditis secondary to SARS-CoV-2 infection; case studies from Turkey. Turkish J Endocrinol Metab (2021) 25(2):232&#x2013;7. doi: 10.25179/tjem.2020-80585</Citation><ArticleIdList><ArticleId IdType="doi">10.25179/tjem.2020-80585</ArticleId></ArticleIdList></Reference><Reference><Citation>Brancatella A, Ricci D, Cappellani D, Viola N, Sgr&#xf2; D, Santini F, et al. . Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? insights from a case series. J Clin Endocrinol Metab (2020) 105(10). doi: 10.1210/clinem/dgaa537</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa537</ArticleId><ArticleId IdType="pmc">PMC7454668</ArticleId><ArticleId IdType="pubmed">32780854</ArticleId></ArticleIdList></Reference><Reference><Citation>Brancatella A, Ricci D, Viola N, Sgr&#xf2; D, Santini F, Latrofa F. Subacute thyroiditis after sars-COV-2 infection. J Clin Endocrinol Metab (2020) 105(7). doi: 10.1210/clinem/dgaa276</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa276</ArticleId><ArticleId IdType="pmc">PMC7314004</ArticleId><ArticleId IdType="pubmed">32436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Barrera E, Alvarez-Cisneros T, Davalos-Fuentes M. Subacute thyroiditis associated with COVID-19. Case Rep Endocrinol (2020) 2020:8891539. doi: 10.1155/2020/8891539</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/8891539</ArticleId><ArticleId IdType="pmc">PMC7522602</ArticleId><ArticleId IdType="pubmed">33005461</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty U, Ghosh S, Chandra A, Ray AK. Subacute thyroiditis as a presenting manifestation of COVID-19: A report of an exceedingly rare clinical entity. BMJ Case Rep (2020) 13(12):e239953. doi: 10.1136/bcr-2020-239953</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-239953</ArticleId><ArticleId IdType="pmc">PMC10577769</ArticleId><ArticleId IdType="pubmed">33370933</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong WH, Shkolnik B, Saha B, Beegle S. Subacute thyroiditis in the setting of coronavirus disease 2019. Am J Med Sci (2020) 361(3):400&#x2013;402. doi: 10.1016/j.amjms.2020.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2020.09.011</ArticleId><ArticleId IdType="pmc">PMC7493794</ArticleId><ArticleId IdType="pubmed">33097194</ArticleId></ArticleIdList></Reference><Reference><Citation>Davoodi L, Oladi Z, Jafarpour H, Zakariaei Z, Soleymani E, Razavi A. A 33-year-old man with COVID-19 presented with subacute thyroiditis: A rare case report and literature review. New Microbes New Infect (2021) 41:100871. doi: 10.1016/j.nmni.2021.100871</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2021.100871</ArticleId><ArticleId IdType="pmc">PMC7982644</ArticleId><ArticleId IdType="pubmed">33777402</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Higuera L&#xf3;pez-Fr&#xed;as M, Perdomo CM, Galofr&#xe9; JC. Subacute thyroiditis following COVID-19 infection. Rev Clin Esp (2021) 221(6):370&#x2013;2. doi:&#xa0;10.1016/j.rceng.2021.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rceng.2021.01.002</ArticleId><ArticleId IdType="pmc">PMC7997620</ArticleId><ArticleId IdType="pubmed">34059237</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolkar T, Jitidhar F, Patel MJ, Hamad AM, Salauddin F, Shiferaw-Deribe Z, et al. . Painless subacute thyroiditis in a patient with acute COVID-19 infection: A transient event. Cureus (2022) 14(7):e26924. doi: 10.7759/cureus.26924</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.26924</ArticleId><ArticleId IdType="pmc">PMC9377795</ArticleId><ArticleId IdType="pubmed">35983391</ArticleId></ArticleIdList></Reference><Reference><Citation>Elawady SS, Phuyal D, Shah RK, Mirza L. A case of subacute thyroiditis following COVID-19 infection. Case Rep Endocrinol (2022) 2022:2211061. doi: 10.1155/2022/2211061</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/2211061</ArticleId><ArticleId IdType="pmc">PMC9174011</ArticleId><ArticleId IdType="pubmed">35685291</ArticleId></ArticleIdList></Reference><Reference><Citation>Feghali K, Atallah J, Norman C. Manifestations of thyroid disease post COVID-19 illness: Report of hashimoto thyroiditis, graves' disease, and subacute thyroiditis. J Clin Transl Endocrinol Case Rep (2021) 22:100094. doi: 10.1016/j.jecr.2021.100094</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jecr.2021.100094</ArticleId><ArticleId IdType="pmc">PMC8387132</ArticleId><ArticleId IdType="pubmed">34462717</ArticleId></ArticleIdList></Reference><Reference><Citation>Guven M. Subacute thyroiditis in the course of coronavirus disease 2019: A case report. J Endocrinol Metab (2020) 10(3-4):110&#x2013;2. doi: 10.14740/jem678</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/jem678</ArticleId></ArticleIdList></Reference><Reference><Citation>Haj&#xf3;si-Kalcakosz S, D&#xe9;nes J, G&#xf3;th M. Subacute thyroiditis associated with COVID-19 infection: A report of an increasing entity. Arch Endocrinol Metab (2022) 66(1):118&#x2013;28. doi: 10.20945/2359-3997000000446</Citation><ArticleIdList><ArticleId IdType="doi">10.20945/2359-3997000000446</ArticleId><ArticleId IdType="pmc">PMC9991023</ArticleId><ArticleId IdType="pubmed">35263053</ArticleId></ArticleIdList></Reference><Reference><Citation>Ippolito S, Dentali F, Tanda ML. SARS-CoV-2: a potential trigger for subacute thyroiditis? insights from a case report. J Endocrinol Invest (2020) 43(8):1171&#x2013;2. doi: 10.1007/s40618-020-01312-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01312-7</ArticleId><ArticleId IdType="pmc">PMC7266411</ArticleId><ArticleId IdType="pubmed">32488726</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakovac H, Ferencic A, Stemberger C, Mohar Vitezic B, Cuculic D. Detection of sars-Cov-2 antigens in thyroid gland showing histopathological features of subacute thyroiditis. Eur Thyroid J (2022) 11(2):e220005. doi: 10.1530/ETJ-22-0005</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/ETJ-22-0005</ArticleId><ArticleId IdType="pmc">PMC8963172</ArticleId><ArticleId IdType="pubmed">35166214</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatri A, Charlap E, Kim A. Subacute thyroiditis from COVID-19 infection: A case report and review of literature. Eur Thyroid J (2021) 9(6):324&#x2013;8. doi:&#xa0;10.1159/000511872</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000511872</ArticleId><ArticleId IdType="pmc">PMC7705942</ArticleId><ArticleId IdType="pubmed">33708634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kliem T, Strobel D, Heinke F, Pavel M, Neurath MF, Neufert C. Fallbericht: Persistierendes Fieber nach SARS-CoV-2-Infektion [Case report: persistent fever after SARS-CoV-2 infection]. Inn Med (Heidelb). (2022) 63(6):662&#x2013;5. German. doi:&#xa0;10.1007/s00108-022-01315-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00108-022-01315-x</ArticleId><ArticleId IdType="pmc">PMC8929463</ArticleId><ArticleId IdType="pubmed">35301546</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong M, Sarah La P. Case report: De quervain&#x2019;s thyroiditis as a long-term sequelae complication to SARS-CoV-2 infection. Case Rep Acute Med (2021) 4(2):64&#x2013;70. doi: 10.1159/000517705</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000517705</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathews SE, Castellanos-Diaz J, Srihari A, Kadiyala S, Leey-Casella J, Ghayee HK, et al. . Subacute thyroiditis and heart failure in a patient presenting with COVID-19. J Investig Med High Impact Case Rep (2021) 9:23247096211009412. doi: 10.1177/23247096211009412</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23247096211009412</ArticleId><ArticleId IdType="pmc">PMC8056563</ArticleId><ArticleId IdType="pubmed">33853424</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattar SAM, Koh SJQ, Chandran SR, Cherng BPZ. Subacute thyroiditis associated with COVID-19. BMJ Case Rep (2020) 13(8):e237336. doi: 10.1136/bcr-2020-237336</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-237336</ArticleId><ArticleId IdType="pmc">PMC7449350</ArticleId><ArticleId IdType="pubmed">32843467</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehmood MA, Bapna M, Arshad M. A case of post-COVID-19 subacute thyroiditis. Cureus (2020) 12(12):e12301. doi: 10.7759/cureus.12301</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.12301</ArticleId><ArticleId IdType="pmc">PMC7832738</ArticleId><ArticleId IdType="pubmed">33510992</ArticleId></ArticleIdList></Reference><Reference><Citation>Osorio Mart&#xed;nez A, Gonz&#xe1;lez-Razo VT, Navarro-S&#xe1;nchez V, Souto Meiri&#xf1;o CA, Ahumada-Ayala M. SARS-CoV-2-Related subacute thyroiditis, myocarditis, and hepatitis after full resolution of COVID-19 serum markers. Am J Case Rep (2021) 22:e932321. doi:&#xa0;10.12659/AJCR.932321</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.932321</ArticleId><ArticleId IdType="pmc">PMC8218950</ArticleId><ArticleId IdType="pubmed">34138828</ArticleId></ArticleIdList></Reference><Reference><Citation>Poudel Jaishi P, Neupane SK, Neupane PK, Koirala D, Kandel A, Joshi K. Case report: Paradoxical manifestation of covid 19 induced thyroiditis in the unvaccinated patient. Ann Med Surg (Lond) (2022) 80:104204. doi: 10.1016/j.amsu.2022.104204</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.104204</ArticleId><ArticleId IdType="pmc">PMC9296224</ArticleId><ArticleId IdType="pubmed">35875056</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruano R, Zorzano-Martinez M, Campos A, Rius F, Hern&#xe1;ndez M. Subacute thyroiditis might be a complication triggered by SARS-CoV-2. Endocrinol Diabetes Nutr (Engl Ed) (2020) 68(10):755&#x2013;6. doi:&#xa0;10.1016/j.endinu.2020.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.endinu.2020.09.002</ArticleId><ArticleId IdType="pmc">PMC7553120</ArticleId><ArticleId IdType="pubmed">33139217</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri RM, Campenn&#xec; A, Siracusa M, Frazzetto G, Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones (Athens) (2021) 20(1):219&#x2013;21. doi: 10.1007/s42000-020-00230-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42000-020-00230-w</ArticleId><ArticleId IdType="pmc">PMC7365600</ArticleId><ArticleId IdType="pubmed">32676935</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehi AM, Salehi H, Mohammadi HA, Afsar J. SARS-CoV-2 and subacute thyroiditis: A case report and literature review. Case Rep Med (2022) 2022:6013523. doi: 10.1155/2022/6013523</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/6013523</ArticleId><ArticleId IdType="pmc">PMC9262519</ArticleId><ArticleId IdType="pubmed">35813005</ArticleId></ArticleIdList></Reference><Reference><Citation>San Juan MDJ, Florencio MQV, Joven MH. SUBACUTE THYROIDITIS IN a PATIENT WITH CORONAVIRUS DISEASE 2019. AACE Clin Case Rep (2020) 6(6):e361-e364. doi:&#xa0;10.4158/ACCR-2020-0524</Citation><ArticleIdList><ArticleId IdType="doi">10.4158/ACCR-2020-0524</ArticleId><ArticleId IdType="pmc">PMC7685420</ArticleId><ArticleId IdType="pubmed">33244504</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato D, Nishiguchi S, Tanaka E. Successful management of subacute thyroiditis following SARS-CoV-2 infection. Intern Med (2021) 60(22):3573&#x2013;6. doi: 10.2169/internalmedicine.7913-21</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.7913-21</ArticleId><ArticleId IdType="pmc">PMC8666218</ArticleId><ArticleId IdType="pubmed">34511569</ArticleId></ArticleIdList></Reference><Reference><Citation>Semikov VI, Aghayan DL, Shulutko AM, Khorobrykh TV, Aleksandrov YK, Mansurova GT, et al. . Subacute thyroiditis after SARS-CoV-2 infection. Clin Case Rep (2021) 9(11):e05109. doi: 10.1002/ccr3.5109</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.5109</ArticleId><ArticleId IdType="pmc">PMC8607799</ArticleId><ArticleId IdType="pubmed">34849227</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyed Resuli A, Bezgal M. Subacute thyroiditis in COVID-19 patients. Ear Nose Throat J (2021) 101(8):501&#x2013;5. doi:&#xa0;10.1177/01455613211012114</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01455613211012114</ArticleId><ArticleId IdType="pubmed">33974811</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohrabpour S, Heidari F, Karimi E, Ansari R, Tajdini A, Heidari F. Subacute thyroiditis in COVID-19 patients. Eur Thyroid J (2021) 9(6):321&#x2013;3. doi:&#xa0;10.1159/000511707</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000511707</ArticleId><ArticleId IdType="pmc">PMC7705932</ArticleId><ArticleId IdType="pubmed">33708633</ArticleId></ArticleIdList></Reference><Reference><Citation>Stasiak M, Zawadzka-Starczewska K, Lewi&#x144;ski A. Clinical manifestation of subacute thyroiditis triggered by SARS-CoV-2 infection can be HLA-dependent. Viruses (2021) 13(12):2447. doi: 10.3390/v13122447</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13122447</ArticleId><ArticleId IdType="pmc">PMC8707017</ArticleId><ArticleId IdType="pubmed">34960716</ArticleId></ArticleIdList></Reference><Reference><Citation>Timofeeva LA, Aleksandrov YK, Aleshina TN, Yusova MA. Subacute thyroiditis associated with covid-19. Russ Electron J Radiol (2021) 11(3):15&#x2013;24. doi: 10.21569/2222-7415-2021-11-3-15-24</Citation><ArticleIdList><ArticleId IdType="doi">10.21569/2222-7415-2021-11-3-15-24</ArticleId></ArticleIdList></Reference><Reference><Citation>Tj&#xf8;nnfjord E, Moe RB, Ghanima W, Aballi S. Subacute thyroiditis after COVID-19. Tidsskr Nor Laegeforen (2021) 141(10). doi: 10.4045/tidsskr.21.0169</Citation><ArticleIdList><ArticleId IdType="doi">10.4045/tidsskr.21.0169</ArticleId><ArticleId IdType="pubmed">34182720</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xdc;n&#xfc;bol M, Erdemir Z, &#xc7;olak G, &#xdc;nsal MG, G&#xfc;ney E. Subacute thyroiditis associated with COVID-19 infection: Two case reports. Turkish J Endocrinol Metab (2021) 25(3):344&#x2013;8. doi:&#xa0;10.25179/tjem.2021-84279</Citation><ArticleIdList><ArticleId IdType="doi">10.25179/tjem.2021-84279</ArticleId></ArticleIdList></Reference><Reference><Citation>Brancatella A, Viola N, Rutigliano G, Sgr&#xf2; D, Santini F, Latrofa F. Subacute thyroiditis during the SARS-CoV-2 pandemic. J Endocr Soc (2021) 5(10):bvab130. doi: 10.1210/jendso/bvab130</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvab130</ArticleId><ArticleId IdType="pmc">PMC8344892</ArticleId><ArticleId IdType="pubmed">34458656</ArticleId></ArticleIdList></Reference><Reference><Citation>Bah&#xe7;ecio&#x11f;lu AB, Karahan ZC, Aydo&#x11f;an BI, Kalkan IA, Azap A, Erdo&#x11f;an MF. Subacute thyroiditis during the COVID-19 pandemic: a prospective study. J Endocrinol Invest (2022) 45(4):865&#x2013;74. doi:&#xa0;10.1007/s40618-021-01718-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01718-x</ArticleId><ArticleId IdType="pmc">PMC8754549</ArticleId><ArticleId IdType="pubmed">35023078</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal S, DasGupta R, Lodh M, Ganguly A. Subacute thyroiditis following recovery from COVID-19 infection: novel clinical findings from an Eastern Indian cohort. Postgraduate Med J (2022) 15:postgradmedj-2021-141429. doi: 10.1136/postgradmedj-2021-141429</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2021-141429</ArticleId><ArticleId IdType="pubmed">37319147</ArticleId></ArticleIdList></Reference><Reference><Citation>Poma A, Bonuccelli D, Giannini R, Macerola E, Vignali P, Ugolini C, et al. . COVID-19 autopsy cases: Detection of virus in endocrine tissues. J Endocrinol Invest (2022) 45(1):209&#x2013;14. doi: 10.1007/s40618-021-01628-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01628-y</ArticleId><ArticleId IdType="pmc">PMC8243303</ArticleId><ArticleId IdType="pubmed">34191258</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu S, et al. . Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: A clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest (2021) 44:1085&#x2013;90. doi: 10.1007/s40618-020-01436-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01436-w</ArticleId><ArticleId IdType="pmc">PMC7538193</ArticleId><ArticleId IdType="pubmed">33025553</ArticleId></ArticleIdList></Reference><Reference><Citation>Stasiak M, Tymoniuk B, Michalak R, Stasiak B, Kowalski ML, Lewi&#x144;ski A. Subacute thyroiditis is associated with HLA-b* 18: 01,-DRB1* 01 and-c* 04: 01&#x2013;the significance of the new molecular background. J Clin Med (2020) 9(2):534. doi: 10.3390/jcm9020534</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020534</ArticleId><ArticleId IdType="pmc">PMC7074389</ArticleId><ArticleId IdType="pubmed">32079059</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanzo N, Patera B, Fazzino GFM, Gallo D, Lai A, Piantanida E, et al. . The old and the new in subacute thyroiditis: An integrative review. Endocrines (2022) 3(3):391&#x2013;410. doi: 10.3390/endocrines3030031</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/endocrines3030031</ArticleId></ArticleIdList></Reference><Reference><Citation>Viola N, Brancatella A, Sgr&#xf2; D, Santini F, Latrofa F. Clinical, biochemical features and functional outcome of patients with SARS-CoV-2-related subacute thyroiditis: a review. Endocrine (2022) 79(3):448&#x2013;54. doi: 10.1007/s12020-022-03247-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-022-03247-w</ArticleId><ArticleId IdType="pmc">PMC9670060</ArticleId><ArticleId IdType="pubmed">36394704</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen J, O'Callaghan K, Sinclair H, Hawke K, Love A, Hajkowicz K, et al. . Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review. Internal Med J (2022) 52(4):522&#x2013;9. doi: 10.1111/imj.15432</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imj.15432</ArticleId><ArticleId IdType="pmc">PMC8446980</ArticleId><ArticleId IdType="pubmed">34139048</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando Y, Ono Y, Sano A, Fujita N, Ono S. Subacute thyroiditis after COVID-19: A literature review. Am J Trop Med Hygi (2022) 107(5):1074. doi: 10.4269/ajtmh.21-1223</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.21-1223</ArticleId><ArticleId IdType="pmc">PMC9709026</ArticleId><ArticleId IdType="pubmed">36067987</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis C, Chalder T. Concern for covid-19 cough, fever and impact on mental health. what about risk of somatic symptom disorder? J Ment Health (2021) 30(5):551&#x2013;5. doi:&#xa0;10.1080/09638237.2021.1875418</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638237.2021.1875418</ArticleId><ArticleId IdType="pubmed">33522343</ArticleId></ArticleIdList></Reference><Reference><Citation>Swee DS, Chng CL, Lim A. Clinical characteristics and outcome of thyroid storm: A case series and review of neuropsychiatric derangements in thyrotoxicosis. Endocr Practi (2015) 21(2):182&#x2013;9. doi: 10.4158/EP14023.OR</Citation><ArticleIdList><ArticleId IdType="doi">10.4158/EP14023.OR</ArticleId><ArticleId IdType="pubmed">25370315</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez R, Nemeroff CB. Inflammatory diseases and their psychiatric manifestations. In: Textbook of medical psychiatry. Washington, DC: American Psychiatric Association Publishing; (2020). p. 229&#x2013;63.</Citation></Reference><Reference><Citation>Stasiak M, Tymoniuk B, Stasiak B, Lewi&#x144;ski A. The risk of recurrence of subacute thyroiditis is HLA-dependent. Int J Mol Sci (2019) 20(5):1089. doi: 10.3390/ijms20051089</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20051089</ArticleId><ArticleId IdType="pmc">PMC6429176</ArticleId><ArticleId IdType="pubmed">30832406</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray I, D&#x2019;Souza B, Sarker P, Agarwal P. Management of subacute thyroiditis&#x2013;a systematic review of current treatment protocols. Int J Gen Med (2022) 15:6425. doi: 10.2147/IJGM.S366784</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S366784</ArticleId><ArticleId IdType="pmc">PMC9365321</ArticleId><ArticleId IdType="pubmed">35966510</ArticleId></ArticleIdList></Reference><Reference><Citation>Stasiak M, Tymoniuk B, Adamczewski Z, Stasiak B, Lewi&#x144;ski A. Sonographic pattern of subacute thyroiditis is HLA-dependent. Front Endocrinol (2019) 10:3&#x2013;. doi: 10.3389/fendo.2019.00003</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2019.00003</ArticleId><ArticleId IdType="pmc">PMC6351437</ArticleId><ArticleId IdType="pubmed">30728805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Xiong X, Hao T, Zhao Y. Evaluation on the diagnostic value of nuclear medicine and ultrasound examination in subacute thyroiditis. Indian J Pharm Sci (2021) 83(1):215&#x2013;9. doi: 10.36468/pharmaceutical-sciences.spl.200</Citation><ArticleIdList><ArticleId IdType="doi">10.36468/pharmaceutical-sciences.spl.200</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariani G, Tonacchera M, Grosso M, Fiore E, Falcetta P, Montanelli L, et al. . The role of nuclear medicine in the clinical management of benign thyroid disorders, part 2: Nodular goiter, hypothyroidism, and subacute thyroiditis. J Nucl Med (2021) 62(7):886 LP&#x2013;95. doi: 10.2967/jnumed.120.251504</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.120.251504</ArticleId><ArticleId IdType="pubmed">33579801</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng W, Tan S, King TFJ. Subacute thyroiditis presenting as a painful suspicious thyroid nodule. Endocrinol Diabetes Metab Case Rep (2022) 2022:21&#x2013;0135. doi: 10.1530/EDM-21-0135. Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EDM-21-0135</ArticleId><ArticleId IdType="pmc">PMC9066567</ArticleId><ArticleId IdType="pubmed">35466082</ArticleId></ArticleIdList></Reference><Reference><Citation>Latrofa F, Ricci D, Bottai S, Brozzi F, Chiovato L, Piaggi P, et al. . Effect of thyroglobulin autoantibodies on the metabolic clearance of serum thyroglobulin. Thyroid (2018) 28(3):288&#x2013;94. doi: 10.1089/thy.2017.0052</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2017.0052</ArticleId><ArticleId IdType="pubmed">29439614</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>